Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $191.9850 (0.07%) ($191.9850 - $191.9850) on Fri. Jul. 7, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.98% (three month average) | RSI | 31 | Latest Price | $191.9850(0.07%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN declines -1.4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) KWEB(30%) FXI(29%) EWY(28%) MCHI(28%) EEM(27%) | Factors Impacting SGEN price | SGEN will decline at least -0.49% in a week (0% probabilities). UUP(-16%) XOP(-12%) VXX(-12%) USO(-11%) TBT(-11%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.49% (StdDev 0.98%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $195.53 | 5 Day Moving Average | $192.84(-0.44%) | 10 Day Moving Average | $193.96(-1.02%) | 20 Day Moving Average | $195.53(-1.81%) | To recent high | -7% | To recent low | 2.1% | Market Cap | $33.38b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |